CLINICAL_TRIALS
trial_result
· 2018-07-23
Clinical Trial Update: Saizen® E-Device User Trial [Phase 3]
Summary
Phase 3 trial evaluating Saizen's E-Device for growth disorders has been completed, with results posted in July 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Growth Disorders | Phase 3 | Status: COMPLETED | Results posted: 2018-07-23